Our definition The company’s position, policy and performance on the pricing of	medicines,	including	tiered	pricing,	differential	pricing,	 capped pricing, early access programmes, Patient Assistance Programmes, royalty-free licensing, pricing transparency, reimbursement strategy, and commercialisation, strategy, availability and registration.